Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Clinical trial NCT00079950 · SUSPENDED
Trial details
- NCT number
- NCT00079950
- Sponsor
- Enzon Pharmaceuticals, Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.